John Connolly is an Epidemiologist in the Therapeutics and Infectious Disease Epidemiology group at the Department of Population Medicine at the Harvard Pilgrim Health Care Institute and Harvard Medical School. He currently works on the FDA-sponsored Sentinel Initiative for drug safety surveillance.  Prior to joining the Department of Population Medicine, Dr. Connolly received both his Sc.M. and Sc.D. in Epidemiology from Harvard T.H.